Mars Bioimaging

Biotechnology, Medical Device, Pharmaceutical
Founded in 2007-01-01
Christchurch, Canterbury, New Zealand
http://www.marsbioimaging.com
For Profit

About Mars Bioimaging

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 10 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 500000 USD
  • Last Funding: 500000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Mars Bioimaging actively uses 10 products in their tech stack.

Market Presence

Industries: Biotechnology, Medical Device, Pharmaceutical

Headquarters: Christchurch, Canterbury, New Zealand